160 related articles for article (PubMed ID: 23377187)
41. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
[TBL] [Abstract][Full Text] [Related]
42. Design and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents.
Oh CH; Kim E; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):423-39. PubMed ID: 21780908
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and evaluation of hexahydropyrimidines and diamines as novel hepatitis C virus inhibitors.
Hwang JY; Kim HY; Jo S; Park E; Choi J; Kong S; Park DS; Heo JM; Lee JS; Ko Y; Choi I; Cechetto J; Kim J; Lee J; No Z; Windisch MP
Eur J Med Chem; 2013; 70():315-25. PubMed ID: 24177358
[TBL] [Abstract][Full Text] [Related]
44. Diosgenin, a plant-derived sapogenin, exhibits antiviral activity in vitro against hepatitis C virus.
Wang YJ; Pan KL; Hsieh TC; Chang TY; Lin WH; Hsu JT
J Nat Prod; 2011 Apr; 74(4):580-4. PubMed ID: 21391660
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves.
Wahyuni TS; Widyawaruyanti A; Lusida MI; Fuad A; Soetjipto ; Fuchino H; Kawahara N; Hayashi Y; Aoki C; Hotta H
Fitoterapia; 2014 Dec; 99():276-83. PubMed ID: 25454460
[TBL] [Abstract][Full Text] [Related]
46. Discovery and structure-activity relationships study of novel thieno[2,3-b]pyridine analogues as hepatitis C virus inhibitors.
Wang NY; Zuo WQ; Xu Y; Gao C; Zeng XX; Zhang LD; You XY; Peng CT; Shen Y; Yang SY; Wei YQ; Yu LT
Bioorg Med Chem Lett; 2014 Mar; 24(6):1581-8. PubMed ID: 24529869
[TBL] [Abstract][Full Text] [Related]
47. Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication.
Clark JL; Hollecker L; Mason JC; Stuyver LJ; Tharnish PM; Lostia S; McBrayer TR; Schinazi RF; Watanabe KA; Otto MJ; Furman PA; Stec WJ; Patterson SE; Pankiewicz KW
J Med Chem; 2005 Aug; 48(17):5504-8. PubMed ID: 16107149
[TBL] [Abstract][Full Text] [Related]
48. Potent and selective inhibition of hepatitis C virus replication by novel phenanthridinone derivatives.
Salim MT; Aoyama H; Sugita K; Watashi K; Wakita T; Hamasaki T; Okamoto M; Urata Y; Hashimoto Y; Baba M
Biochem Biophys Res Commun; 2011 Dec; 415(4):714-9. PubMed ID: 22085716
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and antiviral activity of a novel class of (5-oxazolyl)phenyl amines.
Zhong ZJ; Zhang DJ; Peng ZG; Li YH; Shan GZ; Zuo LM; Wu LT; Li SY; Gao RM; Li ZR
Eur J Med Chem; 2013 Nov; 69():32-43. PubMed ID: 23999140
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and Structure-Activity Relationships of Imidazole-Coumarin Conjugates against Hepatitis C Virus.
Tsay SC; Lin SY; Huang WC; Hsu MH; Hwang KC; Lin CC; Horng JC; Chen IC; Hwu JR; Shieh FK; Leyssen P; Neyts J
Molecules; 2016 Feb; 21(2):. PubMed ID: 26901180
[TBL] [Abstract][Full Text] [Related]
51. A novel class of geldanamycin derivatives as HCV replication inhibitors targeting on Hsp90: synthesis, structure-activity relationships and anti-HCV activity in GS4.3 replicon cells.
Shan GZ; Peng ZG; Li YH; Li D; Li YP; Meng S; Gao LY; Jiang JD; Li ZR
J Antibiot (Tokyo); 2011 Feb; 64(2):177-82. PubMed ID: 21179047
[TBL] [Abstract][Full Text] [Related]
52. Exploration of the in vitro antiviral activity of a series of new pyrimidine analogues on the replication of HIV and HCV.
Jafar NN; Al-Masoudi NA; Baqir SJ; Leyssen P; Pannecouque C
Antivir Chem Chemother; 2012 Sep; 23(3):103-12. PubMed ID: 23010622
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and biological evaluation of α-aryl-α-tetralone derivatives as hepatitis C virus inhibitors.
Manvar D; Fernandes Tde A; Domingos JL; Baljinnyam E; Basu A; Junior EF; Costa PR; Kaushik-Basu N
Eur J Med Chem; 2015 Mar; 93():51-4. PubMed ID: 25644675
[TBL] [Abstract][Full Text] [Related]
54. 2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication.
Keaney EP; Connolly M; Dobler M; Karki R; Honda A; Sokup S; Karur S; Britt S; Patnaik A; Raman P; Hamann LG; Wiedmann B; LaMarche MJ
Bioorg Med Chem Lett; 2014 Aug; 24(16):3714-8. PubMed ID: 25065492
[TBL] [Abstract][Full Text] [Related]
55. Caffeine inhibits hepatitis C virus replication in vitro.
Batista MN; Carneiro BM; Braga AC; Rahal P
Arch Virol; 2015 Feb; 160(2):399-407. PubMed ID: 25491197
[TBL] [Abstract][Full Text] [Related]
56. Characterization and structure-activity relationship study of iminodipyridinopyrimidines as novel hepatitis C virus inhibitor.
Park DS; Jo E; Choi J; Lee M; Kim S; Kim HY; Nam J; Ahn S; Hwang JY; Windisch MP
Eur J Med Chem; 2017 Nov; 140():65-73. PubMed ID: 28923387
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of hepatitis C virus infection by polyoxometalates.
Qi Y; Xiang Y; Wang J; Qi Y; Li J; Niu J; Zhong J
Antiviral Res; 2013 Nov; 100(2):392-8. PubMed ID: 24025401
[TBL] [Abstract][Full Text] [Related]
58. Structure-activity relationship studies on quinoxalin-2(1H)-one derivatives containing thiazol-2-amine against hepatitis C virus leading to the discovery of BH6870.
Zhong QF; Liu R; Liu G
Mol Divers; 2015 Nov; 19(4):829-53. PubMed ID: 26205408
[TBL] [Abstract][Full Text] [Related]
59. Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid.
Ai T; Qiu L; Xie J; Geraghty RJ; Chen L
Bioorg Med Chem; 2016 Feb; 24(4):686-92. PubMed ID: 26753813
[TBL] [Abstract][Full Text] [Related]
60. Retinoids and rexinoids inhibit hepatitis C virus independently of retinoid receptor signaling.
Murakami Y; Fukasawa M; Kaneko Y; Suzuki T; Wakita T; Fukazawa H
Microbes Infect; 2014 Feb; 16(2):114-22. PubMed ID: 24177211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
